AOCNP flashcards
AOCNP · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Hallmarks of cancer
- Sustained proliferation, evasion of growth suppressors, apoptosis resistance, replicative immortality, angiogenesis, invasion and metastasis, and immune evasion are acquired capabilities enabling malignant growth.
- Oncogene vs tumor suppressor
- Oncogenes are gain-of-function drivers acting dominantly, such as RAS and MYC; tumor suppressors require loss of both alleles, such as TP53 and RB1, to remove growth restraint.
- TNM staging meaning
- T describes primary tumor size or invasion, N regional lymph node involvement, and M distant metastasis; the combined stage guides prognosis and therapy selection.
- Tumor grade
- Grade describes how differentiated tumor cells appear; well-differentiated low-grade tumors resemble normal tissue and generally have a better prognosis than poorly differentiated high-grade tumors.
- Paraneoplastic hypercalcemia
- Squamous cell lung cancer and multiple myeloma can secrete PTHrP or cause bone destruction, producing hypercalcemia with confusion, constipation, polyuria, and dehydration.
- SIADH in small cell lung
- Small cell lung cancer may cause syndrome of inappropriate ADH with euvolemic hyponatremia, concentrated urine, and low serum osmolality; treatment includes fluid restriction.
- Cell cycle checkpoints
- G1/S and G2/M checkpoints verify DNA integrity before replication and mitosis; loss of checkpoint control permits mutation accumulation and is targeted by some therapies.
- Lung cancer screening criteria
- Annual low-dose CT is recommended for adults aged 50 to 80 with at least 20 pack-years who currently smoke or quit within 15 years, after shared decision-making.
- Colorectal screening start
- Average-risk adults begin colorectal cancer screening at age 45 with colonoscopy every 10 years or annual FIT; hereditary syndromes or family history require earlier screening.
- BRCA1/2 inheritance
- BRCA1/2 pathogenic variants are autosomal dominant and raise lifetime breast and ovarian cancer risk; genetic counseling guides surveillance and risk-reducing surgery decisions.
- Sensitivity and specificity
- Sensitivity is true positives divided by all people with disease; specificity is true negatives divided by all people without disease; positive predictive value also depends on prevalence.
- Lynch syndrome
- Mismatch repair gene mutations cause Lynch syndrome, increasing colorectal and endometrial cancer risk; tumors typically show microsatellite instability or loss of MMR protein expression.
- Core needle biopsy
- Core needle biopsy removes tissue cores for histology and biomarker testing; it is preferred over fine-needle aspiration when tumor architecture or receptor status is needed.
- Neoadjuvant vs adjuvant
- Neoadjuvant therapy is given before surgery to shrink tumor and assess response; adjuvant therapy follows surgery to eradicate micrometastases and reduce recurrence risk.
- SBRT
- Stereotactic body radiation therapy delivers high-dose radiation in few fractions with precise targeting, used for small lung tumors, oligometastases, and some prostate cancers.
- Cell-cycle-specific chemotherapy
- Antimetabolites act mainly in S phase, while taxanes and vinca alkaloids act in M phase; alkylating agents and platinum compounds are cell-cycle nonspecific DNA-damaging agents.
- Checkpoint inhibitor mechanism
- PD-1, PD-L1, and CTLA-4 inhibitors release brakes on T cells, restoring antitumor immunity; immune-related adverse events can affect skin, gut, lungs, liver, and endocrine organs.
- Trastuzumab target
- Trastuzumab is a monoclonal antibody against HER2, used in HER2-amplified breast and gastric cancers; baseline and periodic cardiac function monitoring is required.
- Autologous transplant
- Autologous stem cell transplant uses the patient's own collected stem cells to rescue bone marrow after high-dose chemotherapy, commonly in multiple myeloma and lymphoma.
- Phase III trial
- Phase III trials compare a new treatment with standard therapy in large populations to measure efficacy and adverse effects; results support regulatory approval and practice change.
- Febrile neutropenia definition
- Fever of 38.3 C once or 38.0 C sustained plus absolute neutrophil count below 500 cells/microL; obtain cultures and start empiric broad-spectrum antibiotics promptly.
- Opioid conversion
- When switching opioids, calculate the equianalgesic dose, reduce for incomplete cross-tolerance, and reassess; oral morphine to intravenous morphine is approximately 3 to 1.
- Highly emetogenic prophylaxis
- Regimens such as cisplatin require a 5-HT3 antagonist, an NK1 receptor antagonist, and dexamethasone, often with olanzapine, before and after chemotherapy.
- Tumor lysis syndrome
- Rapid tumor cell death releases potassium, phosphate, and nucleic acids, causing hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia; treat with hydration and urate-lowering therapy.
- Hospice eligibility
- Hospice is appropriate when prognosis is about 6 months or less and goals focus on comfort; palliative care can be provided alongside curative treatment.
- Hypercalcemia management
- Intravenous fluids restore volume, bisphosphonates or denosumab inhibit bone resorption, and calcitonin lowers calcium rapidly; monitor renal function and electrolytes.
- Survivorship care plan
- A survivorship care plan summarizes cancer treatment, surveillance schedule, potential late effects, health promotion, and coordination between oncology and primary care.
- Anthracycline cardiotoxicity
- Doxorubicin and related drugs cause dose-dependent cardiomyopathy; baseline and periodic ejection fraction monitoring with echocardiography or MUGA is recommended, especially with cardiac risk factors.
- Fertility preservation
- Before gonadotoxic therapy, discuss sperm banking, oocyte or embryo cryopreservation, and possibly ovarian suppression; referral should occur before treatment starts.
- Distress screening
- Use a validated tool such as the NCCN Distress Thermometer at diagnosis and intervals; distress affects adherence and quality of life and warrants appropriate referral.
- Lymphedema risk reduction
- After axillary surgery or radiation, monitor arm circumference, educate about skin care and gradual exercise, and refer for compression or physical therapy if swelling occurs.
- Chemotherapy-induced neuropathy
- Taxanes, platinum agents, and vinca alkaloids can cause sensory peripheral neuropathy; assess gait, falls, and function, and adjust treatment when symptoms are severe.